Valuation: Omnicell, Inc.

Market Cap 1.86B 1.63B 1.51B 1.39B 2.62B 179B 2.66B 18B 7.04B 87.69B 6.97B 6.83B 303B P/E 2026 *
52.4x
P/E 2027 * 41.3x
Enterprise Value 1.86B 1.63B 1.51B 1.39B 2.62B 179B 2.66B 18B 7.04B 87.69B 6.97B 6.83B 303B EV / Sales 2026 *
1.49x
EV / Sales 2027 * 1.41x
Free-Float
76.27%
Yield 2026 *
-
Yield 2027 * -
1 day-2.32%
1 week-11.06%
Current month-1.59%
1 month+4.64%
3 months+11.18%
6 months-19.06%
Current year-9.80%
1 week 40.44
Extreme 40.44
48.06
1 month 37.89
Extreme 37.89
48.06
Current year 31.75
Extreme 31.75
55
1 year 27.77
Extreme 27.77
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
President 50 2026-06-30
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Sell

Chief Executive Officer

-10,000 0.0220%
7/1/26 Free

Chairperson

12,309 0.0271%
6/1/26 Free

Director

4,627 0.0102%
Change 5-day change 1-year change 3-year change Capi.($)
-2.32%-11.06%+45.77%-35.33% 1.9B
-2.48%-4.42%-34.32%-7.59% 30.74B
-3.66%-10.98%-46.05%+160.83% 13.18B
+1.12%-4.56%-24.32%+57.50% 5.35B
-4.76%-4.94% - - 2.19B
-3.41%-2.18% - - 1.84B
-4.20%-6.07%+37.90%+99.54% 893M
-2.10%-3.55%-42.81%-56.65% 762M
-4.79%-10.02%-42.93%-82.15% 658M
-2.14%-9.87%+495.65%+730.30% 649M
Average -2.87%-4.68%+48.61%+108.31% 5.82B
Weighted average by Cap. -2.57%-3.84%-26.06%+47.89%

Financials

2026 *2027 *
Net sales 1.25B 1.09B 1.02B 933M 1.76B 120B 1.78B 12.08B 4.73B 58.85B 4.68B 4.58B 203B 1.32B 1.15B 1.07B 984M 1.85B 127B 1.88B 12.74B 4.98B 62.06B 4.94B 4.83B 215B
Net income 35.72M 31.31M 29.09M 26.72M 50.3M 3.45B 51.11M 346M 135M 1.69B 134M 131M 5.83B 45.83M 40.17M 37.33M 34.28M 64.54M 4.42B 65.58M 444M 174M 2.16B 172M 168M 7.47B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
26-07-22 US$40.86 -2.32% 647,005
26-07-21 US$41.83 -7.50% 1,579,679
26-07-20 US$45.22 -1.42% 554,164
26-07-17 US$45.87 -2.40% 532,855
26-07-16 US$47.00 +0.38% 467,174
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
40.86USD
Average target price
61.29USD
Spread / Average Target
+49.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock